Separate names with a comma.
U.S. Government Accountability Office - Science & Tech Spotlight: Medical Use of Psychedelics https://www.gao.gov/products/gao-25-108021
Congressional Psychedelics Advancing Therapies (PATH) Caucus - Full PDF from Association for Prescription Psychedelics Inc....
March 2025 - Corporate Presentation...
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates...
Oprah - Can Psychedelics Heal Mental Trauma? With Harvard Professor Michael Pollan [MEDIA]
Not sure why the strike through happened. Copy and pasted. Lot's of links to research.
MindMed MM-120 (LSD) in GAD: Recent Research, Regulatory Developments, and Market Impact Recent LSD Research in Mental Health and GAD Growing...
Subject: atai: I have increased my stake from 19.9% to 22.3% by investing 22.75m USD Dear Friends! I am very happy to announce that within the...
Price Target 8-10
Psilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent Portfolio...
Apeiron Investment Group purchases $22.8m in ATAI Life Sciences shares...
Nasdaq is 1.00 minimum. So they may have to RS to get there, but this is a 5-10x play here just on the hype of the uplist. Should be interesting!
NASDAQ Big Moves Ahead: $SWISF Sekur’s Bold 2025 Growth Strategy! Sekur (OTCQB: SWISF) is entering a transformational year—with a Nasdaq...
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months...
This is a good read: After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a...
Sector going to get white hot now. Knew it was going to come back. Was only a matter of time.
FDA Breakthrough Therapy Designation and the Future of MM120...
Potential Acquisition of MindMed by J&J or Similar Pharma Companies: Given Johnson & Johnson’s (J&J) recent acquisition of Intra-Cellular...
Mind Medicine (MindMed) (MNMD) Stock Analysis: 94% Surge, FDA Breakthrough & Phase III Progress [MEDIA]
FDA Under Trump and the Future of Psychedelics...
